Doppler-Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure

Faeq Husain-Syed, Horst-Walter Birk, Claudio Ronco, Tanja Schörmann, Khodr Tello, Manuel J Richter, Jochen Wilhelm, Natascha Sommer, Ewout Steyerberg, Pascal Bauer, Hans-Dieter Walmrath, Werner Seeger, Peter A McCullough, Henning Gall, H Ardeschir Ghofrani, Faeq Husain-Syed, Horst-Walter Birk, Claudio Ronco, Tanja Schörmann, Khodr Tello, Manuel J Richter, Jochen Wilhelm, Natascha Sommer, Ewout Steyerberg, Pascal Bauer, Hans-Dieter Walmrath, Werner Seeger, Peter A McCullough, Henning Gall, H Ardeschir Ghofrani

Abstract

Background Persistent congestion with deteriorating renal function is an important cause of adverse outcomes in heart failure. We aimed to characterize new approaches to evaluate renal congestion using Doppler ultrasonography. Methods and Results We enrolled 205 patients with suspected or prediagnosed pulmonary hypertension (PH) undergoing right heart catheterization. Patients underwent renal Doppler ultrasonography and assessment of invasive cardiopulmonary hemodynamics, echocardiography, renal function, intra-abdominal pressure, and neurohormones and hydration status. Four spectral Doppler intrarenal venous flow patterns and a novel renal venous stasis index (RVSI) were defined. We evaluated PH-related morbidity using the Cox proportional hazards model for the composite end point of PH progression (hospitalization for worsening PH, lung transplantation, or PH-specific therapy escalation) and all-cause mortality for 1-year after discharge. The prognostic utility of RVSI and intrarenal venous flow patterns was compared using receiver operating characteristic curves. RVSI increased in a graded fashion across increasing severity of intrarenal venous flow patterns (P<0.0001) and was significantly associated with right heart and renal function, intra-abdominal pressure, and neurohormonal and hydration status. During follow-up, the morbidity/mortality end point occurred in 91 patients and was independently predicted by RVSI (RVSI in the third tertile versus referent: hazard ratio: 4.72 [95% CI, 2.10-10.59; P<0.0001]). Receiver operating characteristic curves suggested superiority of RVSI to individual intrarenal venous flow patterns in predicting outcome (areas under the curve: 0.789 and 0.761, respectively; P=0.038). Conclusions We propose RVSI as a conceptually new and integrative Doppler index of renal congestion. RVSI provides additional prognostic information to stratify PH for the propensity to develop right heart failure. Clinical Trial Registration URL: https://www.clinicaltrials.gov/. Unique identifier: NCT03039959.

Keywords: cardiorenal syndromes; intrarenal venous flow patterns; pulmonary hypertension; renal Doppler ultrasonography; venous congestion.

Figures

Figure 1
Figure 1
Congestion stages as defined by intrarenal venous flow patterns. Pulsed‐wave Doppler samples of renal congestion patterns in the interlobar renal vessel. The upward Doppler signal shows the intrarenal arterial flow, which is used to measure renal resistive index; the downward Doppler signal shows the venous flow, used to measure venous impedance index or renal venous stasis index. A, No congestion: continuous venous flow. B, Stage 1 congestion: pulsatile venous flow. C, Stage 2 congestion: biphasic venous flow. D, Stage 3 congestion: monophasic venous flow. D indicates diastole; S, systole; VII, venous impedance index.
Figure 2
Figure 2
Renal venous stasis index (RVSI). The RVSI is a novel Doppler‐based parameter to estimate severity of renal congestion. Pulsed‐wave Doppler samples of renal congestion patterns in the interlobar renal vessel are shown. The upward Doppler signal shows the intrarenal arterial flow, which is used to measure cardiac cycle time; the downward Doppler signal shows the venous flow, used to measure venous flow time. Under physiological conditions, the index is zero due to the presence of a continuous venous flow, whereas it increases with rising severity of congestion. The figure illustrates the method of measurement of RVSI in different congestion stages. ms indicates milliseconds.
Figure 3
Figure 3
Study flow chart. The diagram describes the protocol used for the enrollment of patients in this study.
Figure 4
Figure 4
Association of renal venous stasis index with congestion stages. Under physiological conditions, the renal venous stasis index is zero due to the presence of a continuous venous flow, whereas it increases with rising severity of congestion. Horizontal lines indicate median, boxes indicate interquartile range (IQR), and whiskers indicate minimum and maximum values. Data labels show median (IQR).
Figure 5
Figure 5
RVSI and associated clinical parameters. Severity of renal congestion can be evaluated by measurement of RVSI using renal Doppler ultrasonography. The figure illustrates the associations of RVSI tertiles with RAP and renal function (A), right ventricular systolic function and RA area (B), neurohormonal status (C), and hydration status (D). Fluid overload as measured by bioimpedance is likely to occur because of hemodynamic alterations and neurohormonal activation leading to a deterioration of renal function and fluid retention. BNP indicates B‐type natriuretic peptide; eGFR, estimated glomerular filtration rate (based on Chronic Kidney Disease Epidemiology Collaboration creatinine–cystatin C equation); RA, right atrial; RAP, right atrial pressure; RVSI, renal venous stasis index; TAPSE, tricuspid annular plane systolic excursion; VII, venous impedance index.
Figure 6
Figure 6
Kaplan‐Meier estimate curve according to RVSI tertiles. Patients in the third tertile group had a significantly higher probability than other patients of the composite end point of PH‐related morbidity or death from any cause (P<0.0001). PH indicates pulmonary hypertension; RVSI, renal venous stasis index.

References

    1. Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, Jaarsma T, Krum H, Rastogi V, Rohde LE, Samal UC, Shimokawa H, Budi Siswanto B, Sliwa K, Filippatos G. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1:4–25.
    1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63:1123–1133.
    1. Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WH. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589–96.
    1. Damman K, van Deursen VM, Navis G, Voors AA, van Veldhuisen DJ, Hillege HL. Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. J Am Coll Cardiol. 2009;53:582–8.
    1. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS; CHAMPION Trial Study Group . Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377:658–66.
    1. Mullens W, Abrahams Z, Skouri HN, Francis GS, Taylor DO, Starling RC, Paganini E, Tang WH. Elevated intra‐abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? J Am Coll Cardiol. 2008;51:300–6.
    1. Husain‐Syed F, McCullough PA, Birk HW, Renker M, Brocca A, Seeger W, Ronco C. Cardio‐Pulmonary‐Renal Interactions: a Multidisciplinary Approach. J Am Coll Cardiol. 2015;65:2433–48.
    1. Jessup M, Costanzo MR. The cardiorenal syndrome: do we need a change of strategy or a change of tactics? J Am Coll Cardiol. 2009;53:597–9.
    1. Iida N, Seo Y, Sai S, Machino‐Ohtsuka T, Yamamoto M, Ishizu T, Kawakami Y, Aonuma K. Clinical Implications of Intrarenal Hemodynamic Evaluation by Doppler Ultrasonography in Heart Failure. JACC Heart failure. 2016;4:674–82.
    1. Nijst P, Martens P, Dupont M, Tang WHW, Mullens W. Intrarenal Flow Alterations During Transition From Euvolemia to Intravascular Volume Expansion in Heart Failure Patients. JACC Heart failure. 2017;5:672–681.
    1. Puzzovivo A, Monitillo F, Guida P, Leone M, Rizzo C, Grande D, Ciccone MM, Iacoviello M. Renal venous pattern: a new parameter for predicting prognosis in heart failure outpatients. J Cardiovasc Dev Dis. 2018;5:E52.
    1. Beaubien‐Souligny W, Benkreira A, Robillard P, Bouabdallaoui N, Chasse M, Desjardins G, Lamarche Y, White M, Bouchard J, Denault A. Alterations in Portal Vein Flow and Intrarenal Venous Flow Are Associated With Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Cohort Study. J Am Heart Assoc. 2018;7:e009961. doi:10.1161/JAHA.118.009961.
    1. Mehra MR, Park MH, Landzberg MJ, Lala A, Waxman AB; International Right Heart Failure Foundation Scientific Working Group . Right heart failure: toward a common language. J Heart Lung Transplant. 2014;33:123–6.
    1. Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, Aboyans V, Vaz Carneiro A, Achenbach S, Agewall S, Allanore Y, Asteggiano R, Paolo Badano L, Albert Barbera J, Bouvaist H, Bueno H, Byrne RA, Carerj S, Castro G, Erol C, Falk V, Funck‐Brentano C, Gorenflo M, Granton J, Iung B, Kiely DG, Kirchhof P, Kjellstrom B, Landmesser U, Lekakis J, Lionis C, Lip GY, Orfanos SE, Park MH, Piepoli MF, Ponikowski P, Revel MP, Rigau D, Rosenkranz S, Voller H, Luis Zamorano J. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119.
    1. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez‐Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P; ESC Scientific Document Group . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–200.
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work Group. KDIGO . Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2012;2013:1–150.
    1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group . KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
    1. Gall H, Felix JF, Schneck FK, Milger K, Sommer N, Voswinckel R, Franco OH, Hofman A, Schermuly RT, Weissmann N, Grimminger F, Seeger W, Ghofrani HA. The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups. J Heart Lung Transplant. 2017;36:957–967.
    1. Li JC, Jiang YX, Zhang SY, Wang L, Ouyang YS, Qi ZH. Evaluation of renal artery stenosis with hemodynamic parameters of Doppler sonography. J Vasc Surg. 2008;48:323–8.
    1. Sugiura T, Wada A. Resistive index predicts renal prognosis in chronic kidney disease. Nephrol Dial Transplant. 2009;24:2780–5.
    1. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713;quiz 786–788.
    1. Mohmand H, Goldfarb S. Renal dysfunction associated with intra‐abdominal hypertension and the abdominal compartment syndrome. J Am Soc Nephrol. 2011;22:615–21.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guidelines for the six‐minute walk test. Am J Respir Crit Care Med. 2002;166:111–117.
    1. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure. Clin Pharmacol Therap. 1995;57:601–9.
    1. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF III, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD‐EPI (Chronic Kidney Disease Epidemiology Collaboration) . A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.
    1. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD‐EPI Investigators . Estimating glomerular filtration rate from serum creatinine and cystatin C. New Engl J Med. 2012;367:20–9.
    1. R Core Team . R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; Version 3.5.1. 2018. Available at: . Accessed November 20, 2018.
    1. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, Muller M. pROC: an open‐source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
    1. Qiu JC W, Lazarus R, Rosner B, Ma J. powerSurvEpi: power and sample size calculation for survival analysis of epidemiological studies. R package Version 0.1.0. 2018. Available at: . Accessed November 20, 2018.
    1. Freedman LS. Tables of the numbers of patients required in clinical trials using the log‐rank test. Stat Med. 1982;1:121–129.
    1. Tello K, Axmann J, Ghofrani HA, Naeije R, Narcin N, Rieth A, Seeger W, Gall H, Richter MJ. Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension. Int J Cardiol. 2018;266:229–235.
    1. Guazzi M, Dixon D, Labate V, Beussink‐Nelson L, Bandera F, Cuttica MJ, Shah SJ. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: stratification of Clinical Phenotypes and Outcomes. JACC Cardiovasc Imaging. 2017;10:1211–1221.
    1. Burnett JC Jr, Knox FG. Renal interstitial pressure and sodium excretion during renal vein constriction. Am J Physiol. 1980;238:F279–82.
    1. Winton FR. The influence of venous pressure on the isolated mammalian kidney. J Physiol. 1931;72:49–61.
    1. Winton FR. Arterial, Venous, Intrarenal, and Extrarenal Pressure Effects on Renal Blood Flow. Circ Res. 1964;15(SUPPL):103–9.
    1. Avasthi PS, Greene ER, Scholler C, Fowler CR. Noninvasive diagnosis of renal vein thrombosis by ultrasonic echo‐Doppler flowmetry. Kidney Int. 1983;23:882–7.
    1. Jeong SH, Jung DC, Kim SH, Kim SH. Renal venous doppler ultrasonography in normal subjects and patients with diabetic nephropathy: value of venous impedance index measurements. J Clin Ultrasound. 2011;39:512–8.
    1. Meier M, Johannes Jabs W, Guthmann M, Geppert G, Aydin A, Nitschke M. Sonographic Venous Velocity Index Identifies Patients with Chronic Kidney Disease and Severe Diastolic Dysfunction. Ultrasound Int Open. 2018;4:E142–E148.
    1. Haddy FJ, Scott J, Fleishman M, Emanuel D. Effect of change in renal venous pressure upon renal vascular resistance, urine and lymph flow rates. Am J Physiol. 1958;195:97–110.
    1. Lebrie SJ, Mayerson HS. Influence of elevated venous pressure on flow and composition of renal lymph. Am J Physiol. 1960;198:1037–40.
    1. Bateman GA, Cuganesan R. Renal vein Doppler sonography of obstructive uropathy. AJR Am J Roentgenol. 2002;178:921–5.

Source: PubMed

3
Abonneren